Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 26, 2023

SGLT2 Inhibitors vs Sitagliptin in Patients With Heart Failure and Type 2 Diabetes

European Heart Journal


Additional Info

European Heart Journal
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
Eur Heart J 2023 Jun 01;[EPub Ahead of Print], EL Fu, E Patorno, BM Everett, M Vaduganathan, SD Solomon, R Levin, S Schneeweiss, RJ Desai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading